Description and Brand Names
Drug information provided by: Merative, Micromedex®
US Brand Name
- Krazati
Descriptions
Adagrasib is used to treat non-small cell lung cancer (NSCLC) that has spread in patients who have received at least one previous treatment and whose tumors have an abnormal KRAS G12C gene. It is also used in combination with cetuximab to treat colorectal cancer (cancer of the colon or rectum) that has spread in patients who have received other cancer medicines (eg, fluoropyrimidine, oxaliplatin, and irinotecan) and whose tumors have an abnormal KRAS G12C gene.
Adagrasib belongs to the group of medicines called antineoplastics (cancer medicines). It works by interfering with the growth of cancer cells, which are eventually destroyed.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Sept. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.